ResumoObjetivo: Descrever o tratamento dessa patologia com o laser ND YAG1064 ncm. Relato do Caso: A paciente estudada apresentava lesão vascular do tipo hemagioma de lábio inferior irradiando para a face interna da boca, com queixa desde a infância, sem relato de tratamento prévio. Foram realizadas duas sessões de Laser de Nd YAG1064 ncm. Resultados: Houve um resultado satisfatório na regressão da lesão, com cicatriz revestida de colágeno e sem necessidade de sutura. Ao final do tratamento, paciente se apresentou com volume do lábio normal e desaparecimento da coloração azulada característica da doença, relatando estar satisfeita com a escolha do método. Considerações finais: A conduta em relação ao tratamento dos hemangiomas ainda é muito controversa, contudo dentre as várias opções que hoje existem, o tratamento com o Laser de Nd YAG1064 ncm, se destaca como o de padrão-ouro , dentre os diversos tipos de lasers. Palavras-chave:Hemangioma. Terapia combinada. Lasers. AbstractObjective: This report aims to describe the treatment of this pathology with ND YAG1064 nm laser. Case report: The patient studied had vascular lesion of the hemangioma type on the bottom lip extending to the inner part of the mouth, with complaints since childhood, and no history of previous treatment. Two ND YAG1064 nm laser sessions were held. Results: There was a satisfactory result in the regression of the lesion, with scar collagen coated without the need of suturing. At the end of the treatment, the patient came up with a normal lip volume and disappearance of the blue coloration that is a characteristic of the disease. She reported to be satisfied with the choice of the method. Final considerations:: The treatment of hemangiomas is still very controversial, however among the various treatment options there are nowadays, the one with ND YAG1064 nm laser, it is highlighted as gold standard among the various types of lasers.

Background Sudden cardiac death (SCD) is the most feared manifestation of heart disease. In the past few decades, substantial progress has been made in our understanding of SCD and in its prevention. However, there is no data concerning population incidence of SCD in Brazil. Purpose To estimate trends of mortality for SCD in Brazil between 1996 and 2015. Methods Data from death certificates in Brazil from 1996 to 2015 were obtained by consulting the Mortality Information System (SIM) national database. SCD was defined as deaths occurring out of the hospital (residence or public way) with an underlying cause of death reported as a cardiac disease (ICD-9 code 390–398, 402, or 404–429; ICD-10 code I00-I09, I11, I20-I51). Annual death rates (deaths/100,000 inhabitants) were calculated for the population aged ≥20 years and standardized by the direct method to the 2010 Brazilian Census population. Trend analyses in the period were performed using Poisson regression. Results In 2015, there were 200,372 cardiac disease deaths among Brazilian adult population, of which 63,390 (31.6%) were defined as SCD. Over this 20-years period, 1,002,648 deaths were attributed to SCD, and coronary heart disease was the underlying cause on 59% of death certificates. The adjusted mortality rate ranged from 52.9 in 1996 to 39.7 deaths/100,000 inhabitants in 2015 (R2=0.685, P<0.001). This reduction in SCD mortality was more pronounced among women (50.4 to 34.0 deaths/100,000 inhabitants; R2=0.785, P<0.001) than men (59.7 to 49.9 deaths/100,000 inhabitants; R2=0.477, P=0.03). With the exception of individuals aged 20 to 39 years, in the all other age groups this reduction in mortality was also significant. Conclusions This data gives an insight into the pattern of SCD deaths in a big developing country. Despite the inherent limitations in collecting information based on death certificates, in addition to the absence of a clear national standardized definition of SCD, it is possible to affirm that there was a reduction in mortality due to SCD in the last 20 years in Brazil. Prospective surveillance programs would enable more accurate determination of SCD burden in the community.

No abstract